Shandong, China

Yaning Wang

This inventor holds 1 USPTO granted patent. Top assignee: Qilu Pharmaceutical Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yaning Wang. Retrieved from https://idiyas.com/inventor/yaning-wang-f4cb5ugg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yaning Wang: Innovator in Cancer Treatment

Introduction

Yaning Wang is a prominent inventor based in Shandong, China. He has made significant contributions to the field of cancer treatment through his innovative research and development of antibodies.

Latest Patents

Yaning Wang holds a patent for an "Antibody against claudin 18A2 and use thereof." This patent includes an anti-CLDN18.2 antibody or an antigen-binding fragment thereof, along with a derivative comprising said antibody or antigen-binding fragment. The pharmaceutical composition and related uses of this antibody are aimed at treating, diagnosing, and detecting cancers. He has 1 patent to his name.

Career Highlights

Yaning Wang is associated with Qilu Pharmaceutical Co., Ltd., where he has been instrumental in advancing cancer therapies. His work focuses on developing innovative solutions that can significantly impact patient care and treatment outcomes.

Collaborations

Yaning Wang collaborates with notable colleagues, including Yingying Yang and Gao Li. Their combined expertise enhances the research and development efforts within their organization.

Conclusion

Yaning Wang's contributions to cancer treatment through his patented innovations highlight his role as a key figure in the pharmaceutical industry. His work continues to pave the way for advancements in medical science and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…